United Kingdom (UK) Gastric Cancer Drug Market (2025-2031) | Industry, Size & Revenue, Competitive Landscape, Outlook, Trends, Share, Value, Segmentation, Companies, Growth, Analysis, Forecast

Market Forecast By Type (Adenocarcinoma, Lymphoma, Gastrointestinal Stromal Tumor, Carcinoid Tumor, Others, Treatment Type, Chemotherapy), By Drug Type (Doxorubicin Hydrochloride, Sunitinib Mitomycin, Imatinib, Fluorouracil, Trastuzumab, Others), By Route of Administration (Oral, injectable), By End- Users (Hospitals, Homecare, Specialty Clinics, Others) And Competitive Landscape
Product Code: ETC9945134 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United Kingdom (UK) Gastric Cancer Drug Market Outlook
  • Market Size of United Kingdom (UK) Gastric Cancer Drug Market, 2024
  • Forecast of United Kingdom (UK) Gastric Cancer Drug Market, 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Revenues & Volume for the Period 2021- 2031
  • United Kingdom (UK) Gastric Cancer Drug Market Trend Evolution
  • United Kingdom (UK) Gastric Cancer Drug Market Drivers and Challenges
  • United Kingdom (UK) Gastric Cancer Drug Price Trends
  • United Kingdom (UK) Gastric Cancer Drug Porter's Five Forces
  • United Kingdom (UK) Gastric Cancer Drug Industry Life Cycle
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Type for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Adenocarcinoma for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Lymphoma for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Gastrointestinal Stromal Tumor for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Carcinoid Tumor for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Treatment Type for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Chemotherapy for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Drug Type for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Doxorubicin Hydrochloride for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Sunitinib Mitomycin for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Imatinib for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Fluorouracil for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Trastuzumab for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Oral for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By injectable for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By End- Users for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Homecare for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Specialty Clinics for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume By Others for the Period 2021- 2031
  • United Kingdom (UK) Gastric Cancer Drug Import Export Trade Statistics
  • Market Opportunity Assessment By Type
  • Market Opportunity Assessment By Drug Type
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By End- Users
  • United Kingdom (UK) Gastric Cancer Drug Top Companies Market Share
  • United Kingdom (UK) Gastric Cancer Drug Competitive Benchmarking By Technical and Operational Parameters
  • United Kingdom (UK) Gastric Cancer Drug Company Profiles
  • United Kingdom (UK) Gastric Cancer Drug Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United Kingdom (UK) Gastric Cancer Drug Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United Kingdom (UK) Gastric Cancer Drug Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United Kingdom (UK) Gastric Cancer Drug Market Overview

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Gastric Cancer Drug Market - Industry Life Cycle

3.4 United Kingdom (UK) Gastric Cancer Drug Market - Porter's Five Forces

3.5 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.7 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume Share, By End- Users, 2021 & 2031F

4 United Kingdom (UK) Gastric Cancer Drug Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing incidence of gastric cancer in the UK

4.2.2 Advancements in drug development and targeted therapies for gastric cancer

4.2.3 Growing awareness and screening programs for early detection of gastric cancer

4.3 Market Restraints

4.3.1 Stringent regulatory approval processes for new drugs in the UK

4.3.2 High costs associated with gastric cancer treatment

4.3.3 Limited access to specialized healthcare facilities in certain regions of the UK

5 United Kingdom (UK) Gastric Cancer Drug Market Trends

6 United Kingdom (UK) Gastric Cancer Drug Market, By Types

6.1 United Kingdom (UK) Gastric Cancer Drug Market, By Type

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, By Adenocarcinoma, 2021- 2031F

6.1.4 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, By Lymphoma, 2021- 2031F

6.1.5 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumor, 2021- 2031F

6.1.6 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, By Carcinoid Tumor, 2021- 2031F

6.1.7 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, By Others, 2021- 2031F

6.1.8 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, By Treatment Type, 2021- 2031F

6.2 United Kingdom (UK) Gastric Cancer Drug Market, By Drug Type

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, By Doxorubicin Hydrochloride, 2021- 2031F

6.2.3 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, By Sunitinib Mitomycin, 2021- 2031F

6.2.4 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, By Imatinib, 2021- 2031F

6.2.5 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, By Fluorouracil, 2021- 2031F

6.2.6 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, By Trastuzumab, 2021- 2031F

6.2.7 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, By Others, 2021- 2031F

6.3 United Kingdom (UK) Gastric Cancer Drug Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, By injectable, 2021- 2031F

6.4 United Kingdom (UK) Gastric Cancer Drug Market, By End- Users

6.4.1 Overview and Analysis

6.4.2 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, By Homecare, 2021- 2031F

6.4.4 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.4.5 United Kingdom (UK) Gastric Cancer Drug Market Revenues & Volume, By Others, 2021- 2031F

7 United Kingdom (UK) Gastric Cancer Drug Market Import-Export Trade Statistics

7.1 United Kingdom (UK) Gastric Cancer Drug Market Export to Major Countries

7.2 United Kingdom (UK) Gastric Cancer Drug Market Imports from Major Countries

8 United Kingdom (UK) Gastric Cancer Drug Market Key Performance Indicators

8.1 Survival rates of patients diagnosed with gastric cancer

8.2 Adoption rate of innovative treatment options in the UK

8.3 Patient satisfaction with the quality of gastric cancer care received in the UK

9 United Kingdom (UK) Gastric Cancer Drug Market - Opportunity Assessment

9.1 United Kingdom (UK) Gastric Cancer Drug Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United Kingdom (UK) Gastric Cancer Drug Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.3 United Kingdom (UK) Gastric Cancer Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 United Kingdom (UK) Gastric Cancer Drug Market Opportunity Assessment, By End- Users, 2021 & 2031F

10 United Kingdom (UK) Gastric Cancer Drug Market - Competitive Landscape

10.1 United Kingdom (UK) Gastric Cancer Drug Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Gastric Cancer Drug Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All